The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
Phase II clinical trial of intravesical bacillus Calmette-Guerin (BCG) followed by sunitinib for the treatment of high-risk nonmuscle-invasive bladder cancer (NMIBC).
 
Alexander M. Helfand
No Relationships to Disclose
 
Cheryl T. Lee
No Relationships to Disclose
 
Khaled Hafez
Consulting or Advisory Role - Prometheus
Travel, Accommodations, Expenses - Coloplast
 
Maha Hussain
Consulting or Advisory Role - Genmab; Johnson & Johnson; Paradigm; Synthon
Research Funding - Astellas Pharma (Inst); Genentech (Inst); ImClone Systems (Inst); Lilly (Inst); Medivation (Inst); Millennium (Inst); Pfizer (Inst)
Patents, Royalties, Other Intellectual Property - TITLE: Dual Inhibition of MET and VEGF for the treatment of castration resistant prostate cancer and osteoblastic bone metastases. Applicant/Proprietor Exelexis, Inc. Application No/Patent No. 11764665.4- 1464 Application No/Pa; TITLE: METHOD OF TREATING CANCER Docket No: Serial Number: 224990/10-016P2/311733 61/481/671 Application Filed on: 5/2/2011; TITLE: SYSTEMS AND METHODS FOR TISSUE IMAGING, 3676 Our File: Serial Number: UM-14437/US-1/PRO 60/923,385 UM-14437/US-2/ORD 12/101,7
 
Monica Liebert
Stock and Other Ownership Interests - Amgen; Exact Sciences; Merck; Tekla Life Sciences
Patents, Royalties, Other Intellectual Property - DAKO; EMBD Millipore; Santa Cruz
 
Stephanie Daignault
Research Funding - Pfizer (Inst)
 
Jeffrey Scott Montgomery
No Relationships to Disclose
 
David Christopher Miller
No Relationships to Disclose
 
Linda Drnek
No Relationships to Disclose
 
Brent K. Hollenbeck
No Relationships to Disclose
 
Alon Z. Weizer
Research Funding - Pfizer